Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share
-
Shares outstanding
-
49,720,826
-
Total 13F shares
-
24,217,323
-
Share change
-
+697,585
-
Total reported value
-
$617,976,915
-
Put/Call ratio
-
2017%
-
Price per share
-
$25.52
-
Number of holders
-
82
-
Value change
-
+$18,360,369
-
Number of buys
-
37
-
Number of sells
-
38
Institutional Holders of BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) as of Q2 2023
As of 30 Jun 2023,
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,217,323 shares.
The largest 10 holders included
Deep Track Capital, LP, Paradigm Biocapital Advisors LP, Jefferies Financial Group Inc., First Light Asset Management, LLC, MORGAN STANLEY, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, JANUS HENDERSON GROUP PLC, Candriam S.C.A., Sio Capital Management, LLC, and ARMISTICE CAPITAL, LLC.
This page lists
84
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.